Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases (NCT07202273)

🧪 Interventions in This Study

• simulation-free, single-fraction palliative radiation therapy (RADIATION)

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

1. Participant aged ≥ 18 years.
2. Diagnosis of any cancer with one to two sites of painful and treatable metastatic bone lesions.
3. Bone metastases are causing pain or instability in the opinion of the treating investigator.
4. Amenable to single fraction radiation therapy per the discretion of the treating physician.
5. CT collected within 60 days of registration with adequate visualization of target site as determined by the treating investigator.
6. ECOG Performance Status ≤ 2.
7. Participants must adhere to the following sex and contraceptive/barrier requirements:
8. If participant is of childbearing potential, they must have a negative pregnancy test ≤ 14 days before the planned date of radiation therapy. This may be completed on the day of radiation if results from the pregnancy test are available for review before treatment.
9. For participants of non-child bearing potential: The post-menopausal status will be defined as having been amenorrheic for 12 months without an alternative medical cause or having undergone surgical sterilization (bilateral oophorectomy or hysterectomy). The following age-specific requirements apply:
10. \< 50 years of age:
11. Amenorrheic for ≥ 12 months following cessation of exogenous hormonal treatments; and
12. Luteinizing hormone and follicle-stimulating hormone levels in the post-menopausal range for the institution

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

• Huntsman Cancer Institute/University of Utah — Salt Lake City, Utah

📞 Contact the Study Coordinator

Phone: (801) 585-0115

Email: Rachel.kingsford@hci.utah.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Bone Metastases

• Post-Op Pain Control for Prophylactic Intramedullary Nailing. — St Louis, Missouri
• A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases — Houston, Texas
• Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases — New York, New York
• Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer — Duarte, California
• Registry for Bone Metastases — Basking Ridge, New Jersey

Explore by condition: All Bone Metastases clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.